News

Reeling from the deaths of two patients who took Duchenne muscular dystrophy gene therapy Elevidys, Sarepta is launching a ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
This month, the biggest C-suite news in the restaurant industry was that Restaurant Brands International, parent to Burger King, Popeyes, Tim Horton’s and Firehouse Subs, named a new chief ...
On March 16, 2023, Sarepta issued a press release announcing that “at its late cycle meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA), the U.S. Food ...
Here are the five things you need to know, including the latest on Sarepta, possible changes at the FDA, real estate disputes, and the best time to be a soccer fan.
CAMBRIDGE, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today its board of directors ...
Sarepta Therapeutics Announces Leadership Change and Equity Deal November 26, 2024 — 07:48 am EST Written by TipRanks Auto-Generated Newsdesk for TipRanks -> ...
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...